The COURAGE trial in perspective

Catheterization and Cardiovascular Interventions

Volumn 72, Issue 1, 2008, Pages 54-59

  Prasad, Abhiram ^a   Rihal, Charanjit ^a   Holmes Jr , David R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Medical therapy; Percutaneous coronary intervention; Stable angina

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OUTCOME ASSESSMENT (HEALTH CARE); RESEARCH DESIGN;

EID: 47549086974     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21522     Document Type: Review

References (18)

1. ACC/AHA Task Force on Practice Guidelines. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Catheterization & Cardiovascular Interventions. 2008;71:E1-E40.
2. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
3. Mehta SR, Cannon CP, Fox KAA, et al. Routine vs. Selective invasive strategies in patients with acute coronary syndromes - A collaborative meta-analysis of randomized trials. JAMA 2005;293:2908-2917.
4. Bavry AA, Kumbhani DJ, Rassi AN, et al. Benefit of early invasive therapy in acute coronary syndromes - A meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 2006;48:1319-1325.
5. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused Update of the ACC/AHA. 2004. Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008;117: 296-329.
6. Mehta RH, Roe MT, Chen AY, et al. Changing practice for nonST-segment elevation acute coronary syndromes: trends from the CRUSADE quality improvement initiative (abstr). Circulation 2005;112:II793.
7. Katritsis DG, Ioannides JP. Percutaneous coronary intervention versus conservative therapy in non acute coronary artery disease: A meta analysis. Circulation 2005;111:2906-2912.
8. King SB. Angioplasty is better than medical therapy for alleviating chronic angina pectoris. Arch Intern Med 2005;165:2589-2592.
9. Kereiakes DJ, Teirstein PS, Sarembock IJ, et al. The truth and consequences of the COURAGE Trial. J Am Coll Cardiol 2007;50:1598-1603.
10. Holmes DR, Gersh BJ, Whitlow P, et al. Percutaneous coronary intervention for chronic stable angina: A reassessment. J Am Coll Cardiol Intv 2008; 1:34-43.
11. Boden WE, O'Rourke RA, Teo KK, et al., Veterans Affairs Cooperative Studies Program. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Am Heart J 2006;151: 1173-1179.
12. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;35:1503-1516.
13. Steinberg GA, Steg PG, Bhatt DL, Fonarow GC, Zeymer U, Cannon CP, REACH Registry Investigators. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry). Am J Cardiol 2007;99:1212-1215.
14. Gallagher EJ, Viscoli CM, Horwitz RI. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA 1993;270:742-744.
15. Schomig A, Dibra A, Windecker S, et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 2007;50:1373-1380.
16. Kastrati A, Dibra A, Spaulding C, et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 2007; 28:2706-2713.
17. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis. Lancet 2007;370:937-948.
18. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-1291.